Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418

BACKGROUND: Although switching antiretroviral therapy (ART) in people with human immunodeficiency virus experiencing insomnia due to dolutegravir-related neurotoxicity is well founded upon evidence, there is a lack of proof in regard to the outcome of stopping dolutegravir-based ART in people withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabello-Úbeda, Alfonso, Baeza, Alicia González, García, Jesús Troya, de La Fuente Moral, Sara, Mena, María Novella, Martínez, Adriana Pinto, Micán, Rafael, Górgolas, Miguel, Tascón, Guillermo Cuevas, de Santiago, Alberto Díaz, Morerno, José Sanz, Crestelo, David Rial, Arenzana, Carmen Busca, Serna, José Ignacio Bernardino, Almirón, Mariana Díaz, Cano, Joanna, Esteban, Herminia, Pérez-Valero, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487706/
https://www.ncbi.nlm.nih.gov/pubmed/36147597
http://dx.doi.org/10.1093/ofid/ofac345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487706/
https://www.ncbi.nlm.nih.gov/pubmed/36147597
http://dx.doi.org/10.1093/ofid/ofac345

Ejemplares similares